RT @DraganaObrado20: "Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed…
RT @DraganaObrado20: "Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed…
RT @DraganaObrado20: "Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed…
RT @DraganaObrado20: "Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed…
RT @DraganaObrado20: "Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed…
RT @DraganaObrado20: "Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed…
"Several recent clinical trials of remyelination therapies, including #opicinumab, #clemastine, and GSK239512, showed negative or modest results" Curr Treat Options Neurol. 2019 Jun 28;21(7):34 https://t.co/NGuNWhHscE https://t.co/sZ4iu0qLSF
Remyelination is one of the ultimate goals in MS treatment This is a review on different Approaches to Remyelination Therapies in Multiple Sclerosis Very interesting #multiplesclerosis #ms https://t.co/GnOA5VtjAW
RT @ingentium_ms: Approaches to Remyelination Therapies in #MS #MultipleSclerosis. https://t.co/6pMNiVC3Bv
Approaches to Remyelination Therapies in #MS #MultipleSclerosis. https://t.co/6pMNiVC3Bv